Skip to content

SYNAGEVA BIOPHARMA CORP

CIK 0000911326

← back to feed
Revenue (TTM)
$6.18M
−6.7% YoY Q1 Apr 2015
Net Income (TTM)
−$194.58M
−19.3% YoY Q1 Apr 2015
EPS Diluted (TTM)
−$5.77
−73.2% YoY Q1 Apr 2015
Gross Margin
—
Q1 Apr 2015
Operating Margin
-3,138.1%
Q1 Apr 2015
Net Margin
-3,147.6%
Q1 Apr 2015
Free Cash Flow (TTM)
−$82.64M
Q1 Apr 2015
Cash
$98.58M
Q1 Apr 2015
Total Debt
—
Q1 Apr 2015
Shares Outstanding
37.15M sh
Q1 Apr 2015

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings